马应龙八宝Mabo's品牌怎么样 申请店铺

我要投票 马应龙八宝Mabo's在眼霜行业中的票数:16 更新时间:2024-11-22
马应龙八宝Mabo's是哪个国家的品牌?「马应龙八宝Mabo's」是 马应龙药业集团股份有限公司 旗下著名品牌。该品牌发源于湖北武汉,由创始人陈平经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
马应龙八宝Mabo's怎么样

马应龙是一家经国家商务部认定的中华老字号企业,创始于公元1582年。经过多年持续快速健康发展,马应龙已经成为一家涉足于药品制造、药品研发、药品批发零售、连锁医院等多个领域的专业化多功能国际化的医药类上市公司。

公司与北京大学药学院、中国药科大学等多家科研机构建立了长期的战略合作关系。经国家人事部核准公司与北京大学共同组建了博士后工作站。2009年,马应龙药业集团股份有限公司技术中心被国家发改委、科技部等五部委认定为国家级企业技术中心,马应龙创新药物研发团队被湖北省委组织部认定为首批“湖北省重点产业创新团队”。

马应龙及旗下子公司分别通过了国家药监局GMP、GSP质量管理规范体系认证,获得国际权威机构SGS颁发的环境管理体系ISO14000和职业安全与健康管理体系OHSAS18000的认证,在医药行业内率先实现了“三认证”。在世界品牌实验室、世界经理人周刊联合评估的2009年“中国最具价值品牌500强”排行榜中,马应龙名列第213位,品牌价值达到了40.01亿元。2006年马应龙荣获国家工商总局认定的“驰名保护”。2009年,马应龙被中国非处方药物协会评选为“中国非处方药品牌企业十五强”

公司股票于2004年在上海证券交易所上市,由此获得了持续融资的通道和规范营运的平台。2007年,公司股票被上海证券交易所、中国证券指数公司选定为中国上市公司治理指数样本股,标志着公司治理水平获得社会公众、证券机构及专家的高度认可。

传承四百多年的历史文化,公司逐步形成了具有马应龙特色的企业文化体系。公司秉承“为顾客创造健康,为股东创造财富,为员工创造机会,为社会创造效益”的经营宗旨,倡导“以真修心,以勤修为”的哲学观,倡导“稳健经营、协调发展”的经营观,倡导“资源增值”的价值观,弘扬“龙马精神”的企业精神。马应龙将以实现中药现代化为己任,在品牌经营战略的指引下与时俱进,继往开来。


Ma Yinglong is a Chinese time-honored enterprise recognized by the Ministry of Commerce. It was founded in 1582 ad. After years of sustained, rapid and healthy development, Ma Yinglong has become a professional, multi-functional and international pharmaceutical listed company involved in drug manufacturing, drug research and development, drug wholesale and retail, chain hospitals and other fields. The company has established a long-term strategic cooperation relationship with many scientific research institutions, such as the school of pharmacy of Peking University and China Pharmaceutical University. With the approval of the Ministry of personnel of the people's Republic of China, the company and Peking University jointly set up a postdoctoral workstation. In 2009, the technology center of Ma Yinglong Pharmaceutical Group Co., Ltd. was recognized as a national enterprise technology center by five ministries and commissions including the national development and Reform Commission and the Ministry of science and technology, and the R & D team of Ma Yinglong innovative drugs was recognized as the first batch of "Hubei key industry innovation team" by the Organization Department of Hubei Provincial Committee. Ma Yinglong and its subsidiaries have respectively passed the GMP and GSP quality management standard system certification issued by the State Food and drug administration, obtained the certification of ISO14000 environmental management system and OHSAS18000 occupational safety and health management system issued by the international authoritative agency SGS, and took the lead in realizing the "three certifications" in the pharmaceutical industry. In the 2009 "top 500 most valuable brands in China" list jointly evaluated by world brand laboratory and World Manager weekly, Ma Yinglong ranked 213, with the brand value reaching 4.001 billion yuan. In 2006, Ma Yinglong was awarded "famous protection" by the State Administration for Industry and commerce. In 2009, Ma Yinglong was listed on Shanghai Stock Exchange in 2004 as one of the "top 15 Chinese over-the-counter drug brand enterprises" by China over-the-counter drug association, thus obtaining a channel for continuous financing and a platform for standardized operation. In 2007, the company's stock was selected as the sample stock of China's listed corporate governance index by Shanghai Stock Exchange and China Securities Index company, marking that the level of corporate governance was highly recognized by the public, securities institutions and experts. Inheriting more than 400 years of history and culture, the company has gradually formed a corporate culture system with Ma Yinglong's characteristics. The company adheres to the business tenet of "creating health for customers, creating wealth for shareholders, creating opportunities for employees and creating benefits for the society", advocates the philosophy of "cultivating the heart with sincerity, cultivating the mind with diligence", advocates the business concept of "stable operation and coordinated development", advocates the value concept of "resource added value", and promotes the enterprise spirit of "Longma spirit". Ma Yinglong will take the modernization of traditional Chinese medicine as his duty, keep pace with the times and carry forward the past and open up the future under the guidance of brand management strategy.

本文链接: https://brand.waitui.com/92904fecd.html 联系电话:86-27-87291519

千城特选小程序码

7×24h 快讯

三六零:前三季度基于“360智脑”能力开发的互联网ToC端产品直接收入占整体营收不超2%

36氪获悉,三六零发布股票交易异常波动公告,公司于2024年10月31日披露了《三六零安全科技股份有限公司2024年第三季度报告》,2024年1-9月归属于母公司所有者的净利润为-5.79亿元。2024年前三季度,基于“360智脑”能力开发的互联网ToC端产品所产生的直接收入在整体营业收入占比不超过2%,对公司业绩不构成重大影响。

27分钟前

小鹏MONA哨兵模式将于明年一季度上线

36氪获悉,小鹏汽车董事长何小鹏在微博发文,小鹏MONA即将于2025年第一季度推出哨兵模式。

27分钟前

爱婴室:股东拟减持不超过1%公司股份

36氪获悉,爱婴室发布公告,股东莫锐强的一致行动人茂强投资、莫锐伟拟通过集中竞价交易方式合计减持公司股份不超过138.54万股(即不超过公司总股本的1%)。

27分钟前

顺丰控股在香港上市据悉计划将价格定在区间中点

顺丰控股在香港上市据悉计划将价格定在区间中点。(财联社)

27分钟前

欧洲央行副行长:降息路径比降息幅度更重要

欧洲央行副行长Luis de Guindos表示,央行显然在降息的道路上,但每次货币政策会议的降息幅度并没有那么重要。他补充说,明年薪资增长将放缓,并且欧洲央行预计通胀将向2%的目标靠拢。“如果我们对明年的通胀预测确实成为现实,那么货币政策路径是明确的,”他周五在马德里的一次会议上说。“我们是降息50个基点还是25个基点的问题就不那么重要了。”(新浪财经)

27分钟前

本页详细列出关于MARUBI丸美的品牌信息,含品牌所属公司介绍,MARUBI丸美所处行业的品牌地位及优势。
咨询